Article Details

ATyr shares plunge on trial miss in inflammatory lung disease | BioPharma Dive

Retrieved on: 2025-09-16 04:14:38

Tags for this article:

Click the tags to see associated articles and topics

ATyr shares plunge on trial miss in inflammatory lung disease | BioPharma Dive. View article details on hiswai:

Excerpt

Dive Brief: An experimental drug from biotechnology company aTyr Pharma missed its main goal in a Phase 3 trial, failing to help people with an ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo